Validation of an IgM antibody capture ELISA based on a recombinant nucleoprotein for identification of domestic ruminants infected with Rift Valley fever virus

Journal of Virological Methods

Volumn 177, Issue 2, 2011, Pages 140-146

  Williams, Roy ^a   Ellis, Charlotte Elizabeth ^a   Smith, Shirley Jacqueline ^b   Potgieter, Christiaan Abraham ^b   Wallace, David ^a   Mareledwane, Vuyokazi Epipodia ^a   Majiwa, Phelix Antipas Ochola ^a  

^a ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^b Deltamune (Pty) Ltd   (South Africa)

Author keywords

Antibody capture ELISA; Domestic ruminants; IgM; Recombinant nucleoprotein; Rift Valley fever virus; Validation

Indexed keywords

HORSERADISH PEROXIDASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; NUCLEOPROTEIN; RECOMBINANT NUCLEOPROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; BOVIDS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; IMMUNE RESPONSE; IMMUNOLOGICAL MONITORING; INFECTION RISK; INTERMETHOD COMPARISON; LABORATORY INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; SAFETY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VALIDATION STUDY;

ANIMALS; ANTIBODIES, VIRAL; AREA UNDER CURVE; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNE SERA; IMMUNOGLOBULIN M; LIVESTOCK; NUCLEOCAPSID PROTEINS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; RUMINANTS; SENSITIVITY AND SPECIFICITY;

ARMORACIA RUSTICANA; RIFT VALLEY FEVER VIRUS;

EID: 80053130199     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.07.011     Document Type: Article

References (37)

1. Anderson G.W., Saluzzo J.F., Ksiazek T.G., Smith J.F., Ennis W., Thureen D., Peters C.J., Digoutte J.P. Comparison of in vitro and in vivo systems for propagation of Rift Valley fever virus from clinical specimens. Res. Virol. 1989, 140:129-138.
2. Balkhy H.H., Memish Z.A. Rift Valley fever: an uninvited zoonosis in the Arabian peninsula. Int. J. Antimicrob. Agents 2003, 21:153-157.
3. Breiman R.F., Njenga M.K., Cleaveland S., Sharif S.K., Mbabu M., King L. Lessons from the 2006-2007 Rift Valley fever outbreak in East Africa: Implications for prevention of emerging infectious diseases. Future Virol. 2008, 3:411-417.
4. ® Rift Valley Fever Competition Multi-species ELISA 2010, Congress of the European Association of Veterinary Laboratory Diagnosticians, Lelystad, September.
5. Daubney R., Hudson J.R., Garnham P.C. Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep, cattle and man from East Africa. J. Pathol. Bacteriol. 1931, 34:545-579.
6. Daubney R., Hudson J.R. Rift Valley fever. Lancet 1932, 1:611-612.
7. Davies F.G. Observations on the epidemiology of Rift Valley fever in Kenya. J. Hyg. 1975, 75:219-230.
8. Davoust B., Marie J.L., Boni M. Prevention of zoonoses: creation of a unit for early detection of animal infections. Bull. Acad. Natl. Med. 2008, 192:541-554. (in French).
9. Drosten C., Göttig S., Schilling S., Asper M., Panning M., Schmitz H., Günther S. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J. Clin. Microbiol. 2002, 40:2323-2330.
10. Dufour B., Moutou F., Hattenberger A.M., Rodhain F. Global change: impact, management, risk approach and health measures-the case of Europe. Rev. Sci. Tech. Off. Int. Epizoot. 2008, 27:529-550.
11. Fafetine J.M., Tijhaar E., Paweska J.T., Neves L.C.B.G., Hendriks J., Swanepoel R., Coetzer J.A.W., Egberink H.F., Rutten V.P.M.G. Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants. Vet. Microbiol. 2007, 121:29-38.
12. Gale P., Brouwer A., Ramnial V., Kelly L., Kosmider R., Fooks A.R., Snary E.L. Assessing the impact of climate change on vector-borne viruses in the EU through the elicitation of expert opinion. Epidemiol. Infect. 2010, 138:214-225.
13. Garcia S., Crance J.M., Billecocq A., Peinnequin A., Jouan A., Bouloy M., Garin D. Quantitative realtime PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds. J. Clin. Microbiol. 2001, 39:4456-4461.
14. Gauliard N., Billecocq A., Flick R., Bouloy M. Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis. Virology 2006, 351:170-179.
15. Gerdes G.H. Rift Valley fever. Revue Rev. Sci. Tech. Off. Int. Epizoot. 2004, 23:613-623.
16. Hanley J.A., Mcneil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
17. Jacobson R.H. Factors in selecting serum samples for use in determining the positive/negative threshold (cut-off) in ELISA. IAEA-TECDOC 1998, 1055:25-28.
18. Jansen van Vuuren P., Potgieter A.C., Paweska J.T., Van Dijk A.A. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. J. Virol. Methods 2007, 140:106-114.
19. Magurano F., Nicoletti L. Humoral response in Toscana virus acute neurologic disease investigated by viral-protein-specific immunoassays. Clin. Diagn. Lab. Immunol. 1999, 6:55-60.
20. Martin V., Chevalier V., Ceccato P., Anyamba A., De Simone L., Lubroth J., de La Rocque S., Domenech J. The impact of climate change on the epidemiology and control of Rift Valley fever. Revue Rev. Sci. Tech. Off. Int. Epizoot. 2008, 27:413-426.
21. Meegan J., Le Guenno B., Ksiazek T., Jouan A., Knauert F., Digoutte J.P., Peters C.J. Rapid diagnosis of Rift Valley fever: a comparison of methods for the direct detection of viral antigen in human sera. Res. Virol. 1989, 140:59-65.
22. Nakane P.K., Akira Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J. Histochem. Cytochem. 1974, 22:1084-1091.
23. Niklasson B., Grandien M., Peters C.J., Gargan T.P. Detection of Rift Valley fever virus antigen by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1983, 17:1026-1031.
24. Niklasson B., Peter s.C.J., Grandien M., Wood O. Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1984, 19:225-229.
25. Paweska J.T., Burt F.J., Anthony F., Smith S.J., Grobbelaar A.A., Croft J.E., Ksiazek T.G., Swanepoel R. IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants. J. Virol. Methods 2003, 113:103-112.
26. Paweska J.T., Smith S.J., Wright I.M., Williams R., Cohen A.S., Van Dijk A.A., Grbbelaar A.A., Croft J.E., Swanepoel R., Gerdes G.H. Indirect enzyme-linked immunosorbent assay for the detection of antibody against Rift Valley fever virus in domestic and wild ruminant sera. Onderstepoort J. Vet. Res. 2003, 70:49-64.
27. Paweska J.T., Burt F.J., Swanepoel R. Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans. J. Virol. Methods 2005, 124:173-181.
28. Paweska J.T., Van Vuren P.J., Swanepoel R. Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans. J. Virol. Methods 2007, 146:119-124.
29. Pepin M., Bouloy M., Bird B.H., Kemp A., Paweska J. Rift Valley fever virus (Bunyaviridae:Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet. Res. 2010, 41(61):1-40.
30. Shope R.E., Sather G.E. Arboviruses. Diagnostic Procedures for Viral Rickettsial and Chlamydial Infections 1979, 767-814. American Public Health Association, Washington, DC. E.H. Lenette, N.J. Schmidt (Eds.).
31. Sissoko D., Giry C., Gabrie P., Tarantola A., Pettinelli F., Collet L., D'Ortenzio E., Renault P., Pierre V. Rift Valley fever, Mayotte, 2007-2008. Emerg. Infect. Dis. 2009, 15:568-570.
32. Steyerberg E.W., Harrel F.E., Borsboom G.J., Eijkemans M.J., Vergouwe Y., Habbema J.D. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J. Clin. Epidemiol. 2001, 54:774-781.
33. Swanepoel R. Studies on the epidemiology of Rift Valley Fever. J. S. Afr. Vet. Assoc. 1976, 57:93-94.
34. Swanepoel R., Struthers J.K., Erasmus M.J. Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep. J. Hyg. 1986, 97:331-346.
35. Vapalahti O., Kallio-Kokko H., Narvanen A., Julkunen I., Lundkvist A., Plyusnin A., Lehvaslaiho H., Brummer-Korvenkontia M., Vaheri A., Lankinen H. Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J. Med. Virol. 1995, 46:293-303.
36. Weaver S.C., Reisen W.K. Present and future arboviral threats. Antiviral Res. 2010, 85:328-345.
37. Wright P.F., Nilsson E., Van Rooi E.M.A., Lelenta M., Jeggo M.H. Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibodies in infectious disease diagnosis. Rev. Sci. Tech. Off. Int. Epizoot. 1993, 12:435-450.